Non-Treatment Trials: Surveys, Interviews, and Registries
Not all clinical trials study cancer treatments. Clinical trials also study ways to improve quality of life and reduce side effects, as well as collect...
Read MoreResearching Ways to Make MBC Treatment Easier to Tolerate
Tolerability is the ability to take a medication as recommended without experiencing side effects that cause you to stop taking it or take a reduced dose. Because...
Read MoreMeet the Clinical Trial Team: The Institutional Review Board
Clinical trials are run by a team, and we are continuing our series on the roles of clinical trial team members. This month, we are highlighting the Institutional...
Read MoreIn Memory of Dr. Susan Love
In July 2023, the breast cancer community lost a valued friend, advocate, surgeon, and researcher. Read below for a tribute to Dr. Susan Love. Dr. Susan...
Read MoreThe Latest Research on Inflammatory Breast Cancer
Inflammatory breast cancer is a rare type of breast cancer. Symptoms may include redness, swelling, and nipple inversion, and there is often no lump. Inflammatory...
Read MoreMeet the Clinical Trial Team: The Clinical Trial Sponsor
Clinical trials are run by a team, and we are continuing our series on the roles of clinical trial team members. This month, we are highlighting the clinical...
Read MoreAmerican Association for Cancer Research (AACR) 2023
The AACR recently held its 2023 conference from April 14-19, 2023. Click the links below to learn about MBC-related reports from this meeting. Medscape...
Read MoreAmerican Society for Clinical Oncology (ASCO) 2023
ASCO recently held its 2023 conference from June 2-6, 2023. Click the links below to learn about MBC-related reports from this meeting.  Breastcancer.org...
Read MoreHow is ER Low Used in Clinical Trials?
Your estrogen receptor (ER) status can be found on your pathology report and is shown as a percentage. Breast cancer tumors with 1-10% of cells that are ER...
Read MoreSEARCH OUR SITE
for past articles or specific information.